Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments

Radiotherapy and Oncology

Volumn 86, Issue 1, 2008, Pages 48-54

  Morgan, Andrew M ^a   Knöös, Tommy ^b   McNee, Stuart G ^c   Evans, Chris J ^a   Thwaites, David I ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

Clinical implication; Dose calculation algorithms; Lung tissue; Radiation therapy; Treatment planning

Indexed keywords

ALGORITHM; ARTICLE; CANCER RADIOTHERAPY; INTERMETHOD COMPARISON; LUNG CANCER; LUNG PARENCHYMA; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

ALGORITHMS; HUMANS; MODELS, ANATOMIC; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; THORACIC NEOPLASMS; THORAX;

EID: 38349049217     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.11.033     Document Type: Article

References (32)

1. Knöös T., Wieslander E., Cozzi L., et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 51 (2006) 5785-5807
2. American Association of Medical Physics, Report 85, Tissue inhomogeneity corrections for megavoltage photon beams, 2004, ISBN 1-888340-47-9.
3. Nisbet A., Beange I., Vollmar H.S., Irvine C., Morgan A., and Thwaites D.I. Dosimetric verification of a commercial collapsed cone algorithm in simulated clinical situations. Radiother Oncol 73 (2004) 79-88
4. Irvine C., Morgan A., Crellin A., Nisbet A., and Beange I. The clinical implications of the collapsed cone planning algorithm. Clin Oncol (R Coll Radiol) 16 (2004) 148-154
5. Koelbl O., Krieger T., Haedinger U., Sauer O., and Flentje M. Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam. Strahlenther Onkol 180 (2004) 783-788
6. Haedinger U., Krieger T., Flentje M., and Wulf J. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Int J Radiat Oncol Biol Phys 61 (2005) 239-249
7. Fogliata A., Vanetti E., Albers D., et al. On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations. Phys Med Biol 52 (2007) 1363-1385
8. Miften M., Wiesmeyer M., Monthofer S., and Krippner K. Implementation of FFT convolution and multigrid superposition models in the FOCUS RTP system. Phys Med Biol 45 (2000) 817-833
9. Rogers D.W., Faddegon B.A., Ding G.X., Ma C.M., We J., and Mackie T.R. BEAM: a Monte Carlo code to simulate radiotherapy treatment units. Med Phys 22 (1995) 503-524
10. Kawrakow I. Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc, the new EGS4 version. Med Phys 27 (2000) 485-498
11. Evans C., Thwaites D.I., Morgan A., and Weston S. Monte Carlo modelling with BEAMnrc of the Elekta Beam Modulator for small field use. Radiother Oncol 84 (2007) S228
12. Thwaites D.I., Ambolt P., Bowden J., Cooper M., Evans C., Mcormack S., et al. Commissioning a superposition photon dose calculation mdel against measurement and Monte Carlo and some consequences for lung planning of changing TPS algorithms. Radiother Oncol 84 Suppl 1 (2007) S48
13. De Jaeger K., Hoogeman M.S., Engelsman M., Seppenwoolde Y., Damen E.M.F., Mijnheer B.J., et al. Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. Radiother Oncol 69 (2003) 1-10
14. Miften M.M., Beavis A.W., and Marks L.B. Influence of dose calculation model on treatment plan evaluation in conformal radiotherapy: a three-case study. Med Dosim 27 (2002) 51-57
15. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
16. Hope A.J., Lindsay P.E., El Naqa I., Alaly J.R., Vicic M., Bradley J.D., et al. Modelling radiation pneumonitis risk with clinical, dosimetric and special parameters. Int J Radiat Oncol Biol Phys 65 (2006) 112-124
17. Tsujino K., Hirota S., Kotani Y., Kado T., Yoden E., Fujii O., et al. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys 64 (2006) 1100-1105
18. Kong F.M., Pan C., Eisbruch A., and Ten Haken R.K. Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol 17 (2007) 108-120
19. Seppenwoolde Y., and Lebesque J.V. Partial irradiation of the lung. Semin Radiat Oncol 11 (2001) 247-258
20. Madani I., De Ruyck K., Geominne H., De Neve W., and Thierens H. Van Meerbeeck, J. Predicting risk of radiation-induced lung injury. J Thorac Oncol 2 (2007) 864-874
21. Yorke E.D., Jackson A., Rozenzweig K.E., Brabab L., Liebel S.A., and Ling C.C. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
22. Graham M.V., Purdy J.A., Emami B., Harms W., Bosch W., Lockett M.A., et al. Clinical dose-volume histogram analysis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
23. Rodrigues G., Lock M., D'Souza D., and Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer - a systematic review. Radiother Oncol 71 (2004) 127-138
24. Senan S., De Ruyscher D., Giraud P., Mirimanoff R., and Budach V. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
25. Chang D., Lui C., Dempsey J.F., Palta J.R., Louis D., Morris C., et al. Predicting changes in dose distribution to tumour and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer. Am J Clin Oncol 30 (2007) 57-62
26. Schallenkamp J.M., Miller R.C., Brinkman D.H., Foote T., and Garces Y.I. Incidence of radiation pneumonitis after thoracic irradiation: dose volume correlates. Int J Radiat Oncol Biol Phys 67 (2007) 410-416
27. McNee S.G., Morgan A., Maguire J., Thwaites D., Snee M., and McMenemin R. Effect of calculation algorithms on dose prescription and planning for lung radiotherapy. Lung Cancer 57 (2007) S8-S9
28. Madani M., Vanderstraeten B., Bral S., Coghe M., De Gersem W., De Wagter C., et al. Comparison of 6 MV and 18 MV photons for IMRT treatment of lung cancer. Radiother Oncol 82 (2007) 63-69
29. Seppenwoolde Y., De Jaeger K., Boersma L.J., Belderbos J.S., and Lebesque J.V. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung Cancer. Int J Radiat Oncol Biol Phys 60 (2004) 748-758
30. Jackson A., Yorke E.D., and Rosenzweig K.E. The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols. Semin Radiat Oncol 16 (2006) 260-268 Review
31. Siebers V.J., Keall J.P., Nahum E.A., and Mohan R. Converting absorbed dose to medium to absorbed dose to water for Monte Carlo based photon beam dose calculations. Phys Med Biol 45 (2000) 983-995
32. Dogan N., Siebers J.V., and Keall P.J. Clinical comparison of head and neck and prostate IMRT plans using absorbed dose to medium and absorbed dose to water. Phys Med Biol 51 (2006) 4967-4980